TY  - JOUR
T1  - Review on Diagnosis and Management Approach of Multiple Sclerosis
A1  - Ahamd Elssayed
A1  - Rana Ibrahim AlRgaiba
A1  - Mohammed Khalid AlZalbani
A1  - Mohammed Rajab Jumah Hassan
A1  - Khalid Humaid AlMalki
A1  - Abdulaziz Ali AlGhannam
A1  - Ziyad Fahad AlMudayfir
A1  - Hind Ali Abdourab Mohamed
A1  - Malak Motia Sheikh
A1  - Abdulmalek Ali AlGhamdi
A1  - Sarah Ibrahem AlMarwani
JF  - International Journal of Pharmaceutical Research and Allied Sciences
JO  - Int J Pharm Res Allied Sci
SN  - 2277-3657
Y1  - 2023
VL  - 12
IS  - 1
DO  - 10.51847/GJcJdSPaJm
SP  - 100
EP  - 105
N2  - The most prevalent non-traumatic debilitating illness affecting young individuals is multiple sclerosis (MS) (2).      Both industrialized and emerging nations are seeing an increase in the incidence and prevalence of MS, whose underlying etiology is still unknown. In addition to some well-known environmental variables, such as vitamin D or ultraviolet B light (UVB) exposure, Epstein-Barr virus (EBV) infection, obesity, and smoking, MS is a complicated illness with several genes that can influence disease vulnerability (3). The Medline, Pubmed, Embase, NCBI, and Cochrane databases were searched for studies of patients with non-alcoholic fatty liver disease. Incidence, etiology, and management options were analyzed. The etiopathogenesis of MS is convoluted. The processes through which genetic and environmental risk factors for the illness alter risk are still largely unclear, despite significant improvements in their detection. Discovering these processes might result in the identification of novel and more focused therapy targets as well as disease pathways.
UR  - https://ijpras.com/article/review-on-diagnosis-and-management-approach-of-multiple-sclerosis-1eiifphjebh6koc
ER  -